Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Non-Current Liabilities (2016 - 2025)

STRATA Skin Sciences' Total Non-Current Liabilities history spans 14 years, with the latest figure at $29.2 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities fell 2.28% year-over-year to $29.2 million; the TTM value through Sep 2025 reached $29.2 million, down 2.28%, while the annual FY2024 figure was $29.9 million, 3.77% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $29.2 million at STRATA Skin Sciences, up from $28.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $30.4 million in Q3 2023 and bottomed at $19.1 million in Q2 2021.
  • The 5-year median for Total Non-Current Liabilities is $28.8 million (2023), against an average of $26.5 million.
  • The largest annual shift saw Total Non-Current Liabilities soared 42.25% in 2022 before it dropped 7.37% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $21.2 million in 2021, then skyrocketed by 42.25% to $30.1 million in 2022, then fell by 4.48% to $28.8 million in 2023, then grew by 3.77% to $29.9 million in 2024, then dropped by 2.2% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Total Non-Current Liabilities are $29.2 million (Q3 2025), $28.7 million (Q2 2025), and $29.8 million (Q1 2025).